Home / Atorvastatin / Canada
CA ATC C10AA05 · updated 2 Nov 2026
Atorvastatin shortage in Canada
Is there an Atorvastatin shortage in Canada?
Yes. As of 2 Nov 2026, 11 Atorvastatin products are reported short in Canada, the first since 29 Jun 2016. The company estimate for the return is 27 Nov 2026 (latest 1 Jun 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RATIO-ATORVASTATIN (30) | TEVA CANADA LIMITED | 29 Jun 2016 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RATIO-ATORVASTATIN (100) | TEVA CANADA LIMITED | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | RATIO-ATORVASTATIN (30) | TEVA CANADA LIMITED | 17 May 2017 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | PMSC-ATORVASTATIN (90 & 500) | PHARMASCIENCE INC | 3 Aug 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMSC-ATORVASTATIN (90) | PHARMASCIENCE INC | 3 Aug 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMSC-ATORVASTATIN (90) | PHARMASCIENCE INC | 3 Aug 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ATORVASTATIN (500) | SANIS HEALTH INC | 25 May 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | LIPITOR (3 x 10 BL) | BGP PHARMA ULC | 30 Jul 2026 | 26 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-ATORVASTATIN (90BT) | MYLAN PHARMACEUTICALS ULC | 4 Aug 2026 | 13 Apr 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ATORVASTATIN (90) | SANIS HEALTH INC | 24 Aug 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-ATORVASTATIN (90 BTL) discontinuation | APOTEX INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.